Touch me not
- PMID: 24596647
- PMCID: PMC3937561
- DOI: 10.3402/jchimp.v4.23148
Touch me not
Abstract
Central Poststroke Pain syndrome (CPSP) can occur due to disruption of the somatosensory pathways of the brain at any level such as the thalamus, medulla, or cerebral cortex. It is characterized by sensory abnormalities and hyperesthesia in the part of the body correlating to the central lesion. The treatment of this pain syndrome is often difficult, and it does not usually respond to traditional analgesics. The first line of treatment is drugs aimed at lowering neuronal hyperexcitability, for example, amitriptyline or lamotrigine, with gabapentin considered a second line.
Keywords: Central Poststroke Pain; Déjerine Roussy syndrome; gabapentin; neuropathic pain; thalamic pain syndrome.
Figures
References
-
- Krause T, Brunecker P, Pittl S, Taskin B, Laubisch D, Winter B, et al. Thalamic sensory strokes with and without pain: Differences in lesion patterns in the ventral posterior thalamus. J Neurol Neurosurg Psychiatry. 2012;83(8):776–84. - PubMed
-
- Klit H, Finnerup NB, Jensen TS. Central post-stroke pain: Clinical characteristics, pathophysiology, and management. Lancet Neurol. 2009;8(9):857–68. - PubMed
-
- Flaster M, Meresh E, Rao M, Biller J. Central poststroke pain: Current diagnosis and treatment. Top Stroke Rehabil. 2013;20(2):116–23. - PubMed
-
- Andersen G, Vestergaard K, Ingeman-Nielsen M, Jensen TS. Incidence of central post-stroke pain. Pain. 1995;61(2):187–93. - PubMed
-
- Leijon G, Boivie J. Central post-stroke pain – a controlled trial of amitriptyline and carbamazepine. Pain. 1989;36(1):27–36. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources